Colin D. Godwin

UBE2S elongates ubiquitin chains on APC/C substrates to promote mitotic exit

Mathew J. Garnett, Jörg Mansfeld, Colin D. Godwin et al. · Nature Cell Biology · 2009 · 246 citations · Full text

Protein Function, Mitotic Exit, Cell Division +11

Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation

Roland B. Walter, Boglarka Gyurkocza, B. Storer et al. · Leukemia · 2014 · 211 citations · Full text

Hematological Malignancy, Transplantation, Marrow Transplantation +8

Lithium-carbamazepine neurotoxicity and risk factors

Sashi Shukla, Colin D. Godwin, Mary Miller · American Journal of Psychiatry · 1984 · 111 citations

Psychoactive Drug, Psychiatry, Addiction +15

Alnuctamab (ALNUC; BMS-986349; CC-93269), a B-Cell Maturation Antigen (BCMA) x CD3 T-Cell Engager (TCE), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from a Phase 1 First-in-Human Clinical Study

Sandy W. Wong, Noffar Bar, Laura París et al. · Blood · 2022 · 67 citations

Accuracy of SIE/SIES/GITMO Consensus Criteria for Unfitness to Predict Early Mortality After Intensive Chemotherapy in Adults With AML or Other High-Grade Myeloid Neoplasm

Raffaele Palmieri, Megan Othus, Anna B. Halpern et al. · Journal of Clinical Oncology · 2020 · 49 citations · Full text